Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft
Tweaking immune characteristics of donors and recipients could allow for successful cross-species organ transplantation. Here, the authors show that an anti-CD40 antibody therapy of baboons that received heart transplants from genetically modified pigs is key to their long-term survival.
Main Authors: | Muhammad M. Mohiuddin, Avneesh K. Singh, Philip C. Corcoran, Marvin L. Thomas III, Tannia Clark, Billeta G. Lewis, Robert F. Hoyt, Michael Eckhaus, Richard N. Pierson III, Aaron J. Belli, Eckhard Wolf, Nikolai Klymiuk, Carol Phelps, Keith A. Reimann, David Ayares, Keith A. Horvath |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11138 |
Similar Items
-
Evidence for GTKO/β4GalNT2KO Pigs as the Preferred Organ-source for Old World Nonhuman Primates as a Preclinical Model of Xenotransplantation
by: Yehua Cui, MD, et al.
Published: (2020-08-01) -
Intra-Abdominal Heterotopic Cardiac Xenotransplantation: Pearls and Pitfalls
by: Laura DiChiacchio, et al.
Published: (2019-07-01) -
The Preparation of H13 Steel for TBM Cutter and the Performance Test Close to Working Condition
by: Yong Hu, et al.
Published: (2018-10-01) -
TBM Tunnelling at the Stillwater Mine
by: Eide, Leon Nikolay Røren
Published: (2014) -
Folding structure of analogues of hNPY by CD and 1H NMR
by: Pin-Chun Huang, et al.
Published: (2008)